• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风险因素迷雾中的临床审视:瑞典全科医生对心血管预防药物处方的看法

Clinical Gaze in Risk-Factor Haze: Swedish GPs' Perceptions of Prescribing Cardiovascular Preventive Drugs.

作者信息

Hultberg Josabeth, Rudebeck Carl Edvard

机构信息

Åby Health Care Centre, County Council of Östergötland, Department of Medical and Health Sciences, General Practice, Faculty of Health Sciences, Linköping University, 581 85 Linköping, Sweden.

出版信息

Int J Family Med. 2012;2012:612572. doi: 10.1155/2012/612572. Epub 2012 Nov 18.

DOI:10.1155/2012/612572
PMID:23213524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3506883/
Abstract

Aims. To explore general practitioners' (GPs') descriptions of their thoughts and action when prescribing cardiovascular preventive drugs. Methods. Qualitative content analysis of transcribed group interviews with 14 participants from two primary health care centres in the southeast of Sweden. Results. GPs' prescribing of cardiovascular preventive drugs, from their own descriptions, involved "the patient as calculated" and "the inclination to prescribe," which were negotiated in the interaction with "the patient in front of me." In situations with high cardiovascular risk, the GPs reported a tendency to adopt a directive consultation style. In situations with low cardiovascular risk and great uncertainty about the net benefit of preventive drugs, the GPs described a preference for an informed patient choice. Conclusions. Our findings suggest that GPs mainly involve patients at low and uncertain risk of cardiovascular disease in treatment decisions, whereas patient involvement tends to decrease when GPs judge the cardiovascular risk as high. Our findings may serve as a memento for clinicians, and we suggest them to be considered in training in communication skills.

摘要

目的。探讨全科医生(GPs)在开具心血管预防药物时对其想法和行为的描述。方法。对瑞典东南部两个初级卫生保健中心的14名参与者进行的小组访谈转录本进行定性内容分析。结果。从全科医生自身的描述来看,他们开具心血管预防药物涉及“作为计算对象的患者”和“开药倾向”,这两者在与“我面前的患者”的互动中进行协商。在心血管风险高的情况下,全科医生报告倾向于采用指导性咨询方式。在心血管风险低且预防药物净效益存在很大不确定性的情况下,全科医生表示倾向于让患者做出明智的选择。结论。我们的研究结果表明,全科医生在治疗决策中主要让心血管疾病风险低且不确定的患者参与,而当全科医生判断心血管风险高时,患者参与度往往会降低。我们的研究结果可为临床医生提供警示,我们建议在沟通技巧培训中考虑这些结果。

相似文献

1
Clinical Gaze in Risk-Factor Haze: Swedish GPs' Perceptions of Prescribing Cardiovascular Preventive Drugs.风险因素迷雾中的临床审视:瑞典全科医生对心血管预防药物处方的看法
Int J Family Med. 2012;2012:612572. doi: 10.1155/2012/612572. Epub 2012 Nov 18.
2
GPs' Perceptions of Cardiovascular Risk and Views on Patient Compliance: A Qualitative Interview Study.全科医生对心血管风险的认知及对患者依从性的看法:一项定性访谈研究
Int J Family Med. 2015;2015:214146. doi: 10.1155/2015/214146. Epub 2015 Oct 8.
3
Swedish general practitioners' attitudes towards treatment guidelines - a qualitative study.瑞典全科医生对治疗指南的态度——一项定性研究。
BMC Fam Pract. 2014 Dec 16;15:199. doi: 10.1186/s12875-014-0199-0.
4
Lessons from the failure of implementing the 'Better Care Better Value' prescribing indicator for renin-angiotensin system drugs in England: a qualitative study of general practitioners' perceptions using behavioural change framework.从英国实施“更好的护理更好的价值”血管紧张素转换酶抑制剂处方指标失败中吸取的教训:使用行为改变框架对全科医生认知的定性研究
BMJ Open. 2020 Jun 23;10(6):e035910. doi: 10.1136/bmjopen-2019-035910.
5
General practitioners' perceptions of pharmacists' new services in New Zealand.新西兰全科医生对药剂师新服务的看法。
Int J Clin Pharm. 2012 Apr;34(2):364-73. doi: 10.1007/s11096-012-9617-3. Epub 2012 Feb 23.
6
'Aiming for the stars'--GPs' dilemmas in the prevention of cardiovascular disease in type 2 diabetes patients: focus group interviews.“志存高远”——全科医生在2型糖尿病患者心血管疾病预防中的困境:焦点小组访谈
Fam Pract. 2009 Apr;26(2):109-14. doi: 10.1093/fampra/cmp002. Epub 2009 Feb 10.
7
General practitioners' accounts of how to facilitate consultations with toddlers - an interview study.全科医生关于如何促进与幼儿会诊的叙述——一项访谈研究
Scand J Prim Health Care. 2017 Mar;35(1):3-9. doi: 10.1080/02813432.2017.1287518. Epub 2017 Feb 28.
8
A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs.一项探索影响全科医生新药处方决策因素的定性研究。
Br J Gen Pract. 2003 Feb;53(487):120-5.
9
General practitioners' views on the influence of cost on the prescribing of asthma preventer medicines: a qualitative study.全科医生对成本对哮喘预防药物处方影响的看法:一项定性研究。
Aust Health Rev. 2019 Jul;43(3):246-253. doi: 10.1071/AH17030.
10
General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.新西兰全科医生对药剂师在药物评估及处方开具方面当前及潜在贡献的看法。
J Prim Health Care. 2013 Sep 1;5(3):223-33.

引用本文的文献

1
Dealing with being prescribed cardiovascular preventive medication: a narrative analysis of qualitative interviews with patients with recent acute coronary heart disease in Sweden.处理被开具心血管预防药物的问题:对瑞典近期急性冠心病患者进行定性访谈的叙述分析。
BMJ Open. 2021 Dec 17;11(12):e056677. doi: 10.1136/bmjopen-2021-056677.
2
Patients' and health professionals' attitudes and perceptions towards the initiation of preventive drugs for primary prevention of cardiovascular disease: a systematic review of qualitative studies.患者及健康专业人员对启动心血管疾病一级预防预防性药物的态度和看法:定性研究的系统评价
BJGP Open. 2020 Dec 15;4(5). doi: 10.3399/bjgpopen20X101087. Print 2020 Dec.
3
Patient participation in decision-making about cardiovascular preventive drugs - resistance as agency.患者参与心血管预防药物决策——作为能动性的阻力
Scand J Prim Health Care. 2017 Sep;35(3):231-239. doi: 10.1080/02813432.2017.1288814. Epub 2017 Feb 28.
4
Communicating cardiovascular disease risk: an interview study of General Practitioners' use of absolute risk within tailored communication strategies.沟通心血管疾病风险:一项关于全科医生在个性化沟通策略中使用绝对风险的访谈研究。
BMC Fam Pract. 2014 May 29;15:106. doi: 10.1186/1471-2296-15-106.

本文引用的文献

1
Statins for the primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
Cochrane Database Syst Rev. 2011 Jan 19(1):CD004816. doi: 10.1002/14651858.CD004816.pub4.
2
Views on primary prevention of cardiovascular disease--an interview study with Swedish GPs.心血管疾病一级预防观点——对瑞典全科医生的访谈研究。
BMC Fam Pract. 2010 Jun 2;11:44. doi: 10.1186/1471-2296-11-44.
3
Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check?心血管风险评估指南的系统评价:临床医生应遵循哪些建议进行心血管健康检查?
Arch Intern Med. 2010 Jan 11;170(1):27-40. doi: 10.1001/archinternmed.2009.434.
4
'Aiming for the stars'--GPs' dilemmas in the prevention of cardiovascular disease in type 2 diabetes patients: focus group interviews.“志存高远”——全科医生在2型糖尿病患者心血管疾病预防中的困境:焦点小组访谈
Fam Pract. 2009 Apr;26(2):109-14. doi: 10.1093/fampra/cmp002. Epub 2009 Feb 10.
5
Variations in understanding the drug-prescribing process: a qualitative study among Swedish GPs.对药物处方流程理解的差异:一项针对瑞典全科医生的定性研究
Fam Pract. 2009 Apr;26(2):121-7. doi: 10.1093/fampra/cmn103. Epub 2008 Dec 22.
6
Barriers to adherence to hypertension guidelines among GPs in southern Sweden: a survey.瑞典南部全科医生遵守高血压指南的障碍:一项调查
Scand J Prim Health Care. 2008;26(3):154-9. doi: 10.1080/02813430802202111.
7
Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care.不强化药物治疗的原因:区分“临床惰性”与适当治疗。
J Gen Intern Med. 2007 Dec;22(12):1648-55. doi: 10.1007/s11606-007-0433-8. Epub 2007 Oct 24.
8
GPs' thoughts on prescribing medication and evidence-based knowledge: the benefit aspect is a strong motivator. A descriptive focus group study.全科医生对开药及循证知识的看法:益处方面是一个强大的激励因素。一项描述性焦点小组研究。
Scand J Prim Health Care. 2007 Jun;25(2):98-104. doi: 10.1080/02813430701192371.
9
Making sense of blood pressure values in follow-up appointments for hypertension.理解高血压随访预约中的血压值。
Int J Cardiol. 2008 Jan 11;123(2):108-16. doi: 10.1016/j.ijcard.2006.11.172. Epub 2007 Mar 30.
10
More illness and less disease? A 20-year perspective on chronic disease and medication.更多的病症而非疾病?对慢性病与药物治疗的20年展望。
Scand J Public Health. 2006;34(6):584-8. doi: 10.1080/14034940600703407.